title: Obstructive laryngotracheitis secondary to gentian violet exposure.
authors.affiliation: Pediatric Residency Program of Thomas Jefferson University/A.I. duPont Hospital for Children, Wilmington, Delaware, USA.
authors.forename: D
authors.initials: D
authors.lastname: Baca
authors.forename: C
authors.initials: C
authors.lastname: Drexler
authors.forename: E
authors.initials: E
authors.lastname: Cullen
mesh_terms: D000891:Anti-Infective Agents, Local / Q000009:adverse effects*; D000935:Antifungal Agents / Q000627:therapeutic use; D002180:Candidiasis, Oral / Q000188:drug therapy*; D005260:Female; D005840:Gentian Violet / Q000009:adverse effects*; D006801:Humans; D007231:Infant, Newborn; D007827:Laryngitis / Q000139:chemically induced*; D009761:Nystatin / Q000627:therapeutic use; D014136:Tracheitis / Q000139:chemically induced*
chemical_list: D000891:Anti-Infective Agents, Local; D000935:Antifungal Agents; D009761:Nystatin; D005840:Gentian Violet